Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy
The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune syste...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Online |
| Idioma: | anglès |
| Publicat: |
Frontiers Media SA
2021
|
| Matèries: | |
| Accés en línia: | 25658 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
| _version_ | 1869529362782486528 |
|---|---|
| author | Benjamin Gesundheit Joshua P. Rosenzweig |
| author_browse | Benjamin Gesundheit Joshua P. Rosenzweig |
| author_facet | Benjamin Gesundheit Joshua P. Rosenzweig |
| author_sort | Benjamin Gesundheit |
| collection | Directory of Open Access Books |
| description | The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. Theranostic biomarkers to monitor these therapies in clinical trials serve an important need in this innovative field and demand further research. |
| format | Online |
| id | doab-20.500.12854ir-55224 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media SA |
| publisherStr | Frontiers Media SA |
| record_format | ojs |
| spelling | doab-20.500.12854ir-552242024-03-31T13:10:07Z Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy Benjamin Gesundheit Joshua P. Rosenzweig R5-920 RC581-607 RC254-282 theranostic nanomedicine cancer immunotherapy oncolytic viruses antitumor immunity oncoimmunology gene expression transgenes thema EDItEUR::M Medicine and Nursing The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. Theranostic biomarkers to monitor these therapies in clinical trials serve an important need in this innovative field and demand further research. 2021-02-11T21:38:40Z 2021-02-11T21:38:40Z 2018-02-27 16:16:45 2017 book 25658 16648714 9782889453580 https://directory.doabooks.org/handle/20.500.12854/55224 eng Frontiers Research Topics image/jpeg Attribution 4.0 International https://www.frontiersin.org/books/Oncolytic_Viruses_-_Genetically_Engineering_the_Future_of_Cancer_Therapy/1382 https://www.frontiersin.org/research-topics/5352/oncolytic-viruses---genetically-engineering-the-future-of-cancer-therapy Frontiers Media SA 10.3389/978-2-88945-358-0 10.3389/978-2-88945-358-0 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889453580 193 open access |
| spellingShingle | R5-920 RC581-607 RC254-282 theranostic nanomedicine cancer immunotherapy oncolytic viruses antitumor immunity oncoimmunology gene expression transgenes thema EDItEUR::M Medicine and Nursing Benjamin Gesundheit Joshua P. Rosenzweig Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| title | Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| title_full | Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| title_fullStr | Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| title_full_unstemmed | Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| title_short | Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| title_sort | oncolytic viruses genetically engineering the future of cancer therapy |
| topic | R5-920 RC581-607 RC254-282 theranostic nanomedicine cancer immunotherapy oncolytic viruses antitumor immunity oncoimmunology gene expression transgenes thema EDItEUR::M Medicine and Nursing |
| topic_facet | R5-920 RC581-607 RC254-282 theranostic nanomedicine cancer immunotherapy oncolytic viruses antitumor immunity oncoimmunology gene expression transgenes thema EDItEUR::M Medicine and Nursing |
| url | 25658 |
| work_keys_str_mv | AT benjamingesundheit oncolyticvirusesgeneticallyengineeringthefutureofcancertherapy AT joshuaprosenzweig oncolyticvirusesgeneticallyengineeringthefutureofcancertherapy |